HighPoint Advisor Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $330K | Sell |
3,191
-370
| -10% | -$33K | 0.01% | 555 |
|
|
2026
Q1 | $256K | Sell |
3,561
-49,590
| -93% | -$3.82M | 0.01% | 565 |
|
|
2025
Q4 | $4.22M | Buy |
53,151
+4,222
| +9% | +$333K | 0.09% | 198 |
|
|
2025
Q3 | $3.69M | Sell |
48,929
-781
| -2% | -$53.5K | 0.18% | 98 |
|
|
2025
Q2 | $3.43M | Buy |
49,710
+1,345
| +3% | +$88.2K | 0.18% | 98 |
|
|
2025
Q1 | $3.15M | Buy |
48,365
+1,066
| +2% | +$63.8K | 0.18% | 100 |
|
|
2024
Q4 | $2.6M | Sell |
47,299
-10,401
| -18% | -$583K | 0.14% | 124 |
|
|
2024
Q3 | $3.63M | Sell |
57,700
-17,647
| -23% | -$1.03M | 0.21% | 82 |
|
|
2024
Q2 | $4.76M | Buy |
75,347
+26,604
| +55% | +$1.66M | 0.28% | 65 |
|
|
2024
Q1 | $2.75M | Sell |
48,743
-233
| -0.5% | -$17.8K | 0.19% | 93 |
|
|
2023
Q4 | $3.87M | Buy |
+48,976
| New | +$3.49M | 0.28% | 61 |
|
|
2022
Q2 | $3.96M | Buy |
+42,439
| New | +$4.14M | 0.43% | 48 |
|
|
2021
Q3 | $3.68M | Buy |
43,355
+106
| +0.2% | +$8.88K | 0.36% | 55 |
|
|
2021
Q2 | $3.61M | Buy |
43,249
+19,086
| +79% | +$1.56M | 0.36% | 58 |
|
|
2021
Q1 | $1.79M | Buy |
24,163
+2,669
| +12% | +$194K | 0.21% | 98 |
|
|
2020
Q4 | $1.58M | Sell |
21,494
-739
| -3% | -$48.1K | 0.19% | 103 |
|
|
2020
Q3 | $1.36M | Buy |
22,233
+848
| +4% | +$52.8K | 0.25% | 83 |
|
|
2020
Q2 | $1.38M | Buy |
21,385
+2,587
| +14% | +$163K | 0.3% | 75 |
|
|
2020
Q1 | $1.17M | Buy |
18,798
+566
| +3% | +$37.8K | 0.28% | 72 |
|
|
2019
Q4 | $1.36M | Buy |
18,232
+475
| +3% | +$33.4K | 0.28% | 72 |
|
|
2019
Q3 | $1.29M | Sell |
17,757
-2,579
| -13% | -$153K | 0.28% | 71 |
|
|
2019
Q2 | $1.13M | Buy |
20,336
+5,243
| +35% | +$282K | 0.26% | 78 |
|
|
2019
Q1 | $835K | Buy |
15,093
+1,636
| +12% | +$101K | 0.2% | 99 |
|
|
2018
Q4 | $940K | Buy |
13,457
+570
| +4% | +$42.5K | 0.25% | 95 |
|
|
2018
Q3 | $939K | Buy |
12,887
+79
| +0.6% | +$5.65K | 0.26% | 92 |
|
|
2018
Q2 | $938K | Buy |
12,808
+5
| +0% | +$330 | 0.25% | 100 |
|
|
2018
Q1 | $845K | Buy |
12,803
+1,456
| +13% | +$104K | 0.23% | 113 |
|
|
2017
Q4 | $796K | Buy |
11,347
+1,290
| +13% | +$93.8K | 0.23% | 114 |
|
|
2017
Q3 | $698K | Sell |
10,057
-364
| -3% | -$28.8K | 0.22% | 129 |
|
|
2017
Q2 | $812K | Hold |
10,421
| – | – | 0.26% | 92 |
|
|
2017
Q1 | $812K | Buy |
10,421
+81
| +0.8% | +$6.47K | 0.26% | 92 |
|
|
2016
Q4 | $834K | Buy |
10,340
+1,616
| +19% | +$131K | 0.27% | 91 |
|
|
2016
Q3 | $648K | Sell |
8,724
-5,236
| -38% | -$494K | 0.23% | 115 |
|
|
2016
Q2 | $1.36M | Buy |
13,960
+414
| +3% | +$41.3K | 0.48% | 50 |
|
|
2016
Q1 | $1.37M | Sell |
13,546
-1,818
| -12% | -$177K | 0.84% | 24 |
|
|
2015
Q4 | $1.47M | Buy |
15,364
+4,989
| +48% | +$489K | 0.97% | 23 |
|
|
2015
Q3 | $1M | Buy |
+10,375
| New | +$1.09M | 1.11% | 19 |
|
Other funds holding CVS
HighPoint Advisor Group's CVS Position: Q2 2026 in Review
HighPoint Advisor Group reduced its CVS Health (CVS) stake by 10% in Q2 2026, selling an estimated $33K and leaving 3,191 shares worth $330K. The position accounts for 0.01% of the portfolio, ranked #555.
HighPoint Advisor Group first reported a position in CVS in Q3 2015 and has held it in 37 quarters since. The position peaked at $4.76M in Q2 2024. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- HighPoint Advisor Group held 3,191 shares of CVS Health worth $330K as of Q2 2026.
- HighPoint Advisor Group sold 370 CVS Health shares in Q2 2026, an estimated $33K.
- CVS Health made up 0.01% of HighPoint Advisor Group's portfolio in Q2 2026, its #555 holding.
- HighPoint Advisor Group first reported a position in CVS Health in Q3 2015 and has held it in 37 quarters since.
- HighPoint Advisor Group's CVS Health position peaked at $4.76M in Q2 2024.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.